Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Tablets – lozenges – or pills
Patent
1997-09-23
2000-09-26
Page, Thurman K.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Tablets, lozenges, or pills
424436, 424451, 424449, 424464, 424489, 514617, 514964, 514966, 514962, A61K 3324, A61K 920, A61K 914, A61K 948
Patent
active
061239615
ABSTRACT:
A method for treating or preventing urinary incontinence and other motility disorders involving the urethrogenital tract, by administering to a mammal an effective amount of the R-isomers of 4-diethylamino-2-butynyl cyclohexylphenylglycolate and 4-ethylamino-2-butynyl cyclohexylphenylglycolate and pharmaceutically acceptable salts thereof.
REFERENCES:
patent: 5532278 (1996-07-01), Aberg et al.
patent: 5677346 (1997-10-01), Aberg et al.
patent: 5736577 (1998-04-01), Aberg et al.
The Journal of Pharmacology and Experimental Therapeutics vol. 256, No. 2; 1990; pp 562-567.
The Journal of Pharmacology and Experimental Therapeutics vol. 247, No. 3; 1988; pp. 867-872.
Human and Experimental Toxicology (1991), 10, pp. 225-226.
American Urological Association, Inc. 1997 Annual Meeting publication; Topic No. 17; Apr. 12-17, 1997.
Noronha-Blob et al, "Enantiomers of Oxybutynin: In Vitro Pharmacological Characterization . . . " J. Pharmacol. Exp. Ther. 256 (2), 562-567, 1990.
Bridge Pharma, Inc.
Page Thurman K.
Seidleck Brian K.
LandOfFree
Treating urinary incontinence with (R)-desethyloxybutynin and (R does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treating urinary incontinence with (R)-desethyloxybutynin and (R, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treating urinary incontinence with (R)-desethyloxybutynin and (R will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2097672